...
首页> 外文期刊>Brain: A journal of neurology >Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3.
【24h】

Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3.

机译:Neurotrophin-3可防止糖尿病性神经病周围神经中轴突转运的应力激活蛋白激酶的增强激活。

获取原文
获取原文并翻译 | 示例

摘要

The objective was to determine whether stress-activated protein kinases (SAPKs) mediated the transfer of diabetes-induced stress signals from the periphery to somata of sensory neurons. Thus, we characterized axonal transport of SAPKs in peripheral nerve, studied any alteration in streptozotocin (STZ)-diabetic rats and examined effects of neurotrophin-3 (NT-3) on diabetes-induced events. We demonstrate that c-jun N-terminal kinase (JNK) and p38 are bidirectionally axonally transported at fast rates in sciatic nerve. In STZ-diabetic rats the relative levels of retrograde axonal transport of phosphorylated (activated) JNK and p38 were raised compared with age-matched controls (all data are in arbitrary units and expressed as fold increase over control: JNK 54-56 kDa isoforms, control 1.0 +/- 0.19, diabetic 2.5 +/- 0.26; p38, control 1.0 +/- 0.09, diabetic 2.9 +/- 0.52; both P < 0.05). Transport of total enzyme levels of JNK and p38 and phosphorylated extracellular signal-regulated kinase (ERK) was not significantly altered and anterograde axonal transport of phosphorylated JNK and p38 was unaffected by diabetes. The transcription factor ATF-2, which is phosphorylated and activated by JNK and p38, also exhibited elevated retrograde axonal transport in STZ-diabetic animals (control 1.0 +/- 0.07, diabetic 3.0 +/- 0.41; P < 0.05). Treatment of STZ-diabetic animals with 5 mg/kg human recombinant NT-3 prevented activation of JNK and p38 in sciatic nerve (phosphorylated JNK, control 1.0 +/- 0.09, diabetic 1.95 +/- 0.35, diabetic + NT-3 1.09 +/- 0.12; P < 0.05 diabetic versus others; phosphorylated p38, control 1.0 +/- 0.16, diabetic 4.7 +/- 0.9, diabetic + NT-3 1.19 +/- 0.18; P < 0.05 diabetic versus others). The results show that JNK and p38 are transported axonally and may mediate the transfer of diabetes-related stress signals, possibly triggered by loss of neurotrophic support, from the periphery to the neuronal soma.
机译:目的是确定应激激活的蛋白激酶(SAPKs)是否介导了糖尿病诱导的应激信号从周围神经向感觉神经元躯体的转移。因此,我们表征了周围神经中SAPKs的轴突运输,研究了链脲佐菌素(STZ)糖尿病大鼠的任何变化,并研究了Neurotrophin-3(NT-3)对糖尿病诱发事件的影响。我们证明c军N端激酶(JNK)和p38双向快速地在坐骨神经中轴突运输。在STZ糖尿病大鼠中,磷酸化(激活的)JNK和p38的逆行轴突转运的相对水平与年龄匹配的对照组相比有所提高(所有数据均以任意单位表示,表示为相对于对照组的增加倍数:JNK 54-56 kDa亚型,对照1.0 +/- 0.19,糖尿病2.5 +/- 0.26; p38,对照1.0 +/- 0.09,糖尿病2.9 +/- 0.52;两者P <0.05)。 JNK和p38和磷酸化的细胞外信号调节激酶(ERK)的总酶水平的运输没有明显改变,磷酸化JNK和p38的顺行轴突运输不受糖尿病的影响。被JNK和p38磷酸化并激活的转录因子ATF-2在STZ糖尿病动物中也表现出逆行轴突运输(对照1.0 +/- 0.07,糖尿病3.0 +/- 0.41; P <0.05)。用5 mg / kg人重组NT-3治疗STZ糖尿病动物可预防坐骨神经中JNK和p38的活化(磷酸化JNK,对照1.0 +/- 0.09,糖尿病1.95 +/- 0.35,糖尿病+ NT-3 1.09 + /-0.12;与其他相比,P <0.05糖尿病;磷酸化的p38,对照1.0 +/- 0.16,与糖尿病4.7 +/- 0.9,糖尿病+ NT-3 1.19 +/- 0.18;与其他相比,P <0.05。结果表明,JNK和p38被轴突转运,并可能介导与糖尿病相关的应激信号从外周向神经元躯体的转移,这可能是由于神经营养支持的丧失引起的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号